Transactions

Transactions

  • Agios Biopharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and rare genetic metabolic disorders
  • Urogen Pharma is a clinical-stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology, with a focus on uro-oncology
  • BeiGene is a Chinese clinical-stage, immune-oncology company focused on developing molecularly targeted drugs for the treatment of cancer.
  • Boot Barn is a leading lifestyle retailer of western and work-related footwear, apparel and accessories for men, women and children
  • Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer.
  • Atara is a biopharmaceutical company developing therapies with an initial focus on allogeneic T-cell therapies for cancer, autoimmune, and infectious disease.
  • Blueprint Medicine is a biopharmaceutical company focused on developing therapies for genomically-defined diseases driven by abnormal kinase activation
  • argenx is a clinical-stage biotechnology company developing differentiated antibody-based therapies for the treatment of autoimmune diseases and cancer
  • bluebird is a biotechnology company committed to developing potentially transformative gene therapies for severe genetic diseases and cancer
  • Par Pacific is a growth-oriented company that owns, manages and maintains interests in energy and infrastructure businesses
  • Varsity Brands is a leading provider of sports, cheerleading, and achievement-related products
  • GigCapital is a blank check company
1 2 3 4 ...66 Next